Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25455996)

  • 1. Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.
    Chen L; Lin ZX; Lin GS; Zhou CF; Chen YP; Wang XF; Zheng ZQ
    Hum Pathol; 2015 Jan; 46(1):120-8. PubMed ID: 25455996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
    Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
    World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Distributions in CD34+ Microvascular Niche Patterns of Glioblastoma.
    Chen J; Mao S; He Z; Yang L; Zhang J; Lin JM; Lin ZX
    J Histochem Cytochem; 2022 Jan; 70(1):99-110. PubMed ID: 34751042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathological structure of the perivascular niche in different microvascular patterns of glioblastoma.
    Chen J; Mao S; Li H; Zheng M; Yi L; Lin JM; Lin ZX
    PLoS One; 2017; 12(8):e0182183. PubMed ID: 28771552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.
    Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ambros PF; Ambros IM; Bredel M; Oberhuber G; Rössler K; Budka H; Harris AL; Hainfellner JA
    Brain Pathol; 2003 Apr; 13(2):133-43. PubMed ID: 12744467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.
    Wang SY; Ke YQ; Lu GH; Song ZH; Yu L; Xiao S; Sun XL; Jiang XD; Yang ZL; Hu CC
    J Neurooncol; 2013 May; 112(3):339-45. PubMed ID: 23417321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
    Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
    Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric study of nuclei and microvessels in gliomas and its correlation with grades.
    Boruah D; Deb P; Srinivas V; Mani NS
    Microvasc Res; 2014 May; 93():52-61. PubMed ID: 24657905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm for the standardized assessment of vascular patterns in glioblastoma specimens.
    Preusser M; Birner P; Hainfellner JA
    Clin Neuropathol; 2004; 23(5):238-40. PubMed ID: 15581027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
    Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
    Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
    Manneh Kopp RA; Sepúlveda-Sánchez JM; Ruano Y; Toldos O; Pérez Núñez A; Cantero D; Hilario A; Ramos A; de Velasco G; Sánchez-Gómez P; Hernández-Laín A
    Clin Transl Oncol; 2019 Oct; 21(10):1413-1423. PubMed ID: 30877636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
    Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
    Onguru O; Gamsizkan M; Ulutin C; Gunhan O
    Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
    Suren D; Isiksacan Ozen O
    J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
    Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
    Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vasculogenic mimicry in human gliomas.
    Liu XM; Zhang QP; Mu YG; Zhang XH; Sai K; Pang JC; Ng HK; Chen ZP
    J Neurooncol; 2011 Nov; 105(2):173-9. PubMed ID: 21533525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study.
    Chen Y; Jing Z; Luo C; Zhuang M; Xia J; Chen Z; Wang Y
    Med Oncol; 2012 Mar; 29(1):324-31. PubMed ID: 21161444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma.
    Stadlbauer A; Zimmermann M; Doerfler A; Oberndorfer S; Buchfelder M; Coras R; Kitzwögerer M; Roessler K
    Neuro Oncol; 2018 Oct; 20(11):1536-1546. PubMed ID: 29718366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.